JUNE 28 30, 2018 DUBROVNIK/HR

Transcription

1 BEST PRACTICES AND FUTURE TRENDS IN CANCER IMAGING: OPTIMUM RESULTS + YOUNG RADIOLOGISTS SPECIAL SESSION JUNE 27, 2018 JUNE 28 30, 2018 DUBROVNIK/HR

2 COURSE ORGANISERS AND FACULTY Organisers R. Beets-Tan, Amsterdam/NL The Netherlands Cancer Institute Ch. Herold, Vienna/AT Medical University Vienna Memorial Sloan Kettering Cancer Center A. Laghi, Rome/IT University of Rome Sapienza - I.C.O.T. Candiolo Cancer Centre M. F. Reiser, Munich/DE University Hospitals LMU-Munich Programme Committee M. D Anastasi, Msida/MT Mater Dei Hospital M. Mayerhöfer, Vienna/AT Medical University Vienna Memorial Sloan Kettering Cancer Center Faculty P. Baltzer, Vienna/AT R. Barakat, New York/US A. Baur-Melnyk, Munich/DE R. Beets-Tan, Amsterdam/NL M. von Bergwelt, Munich/DE B. Brkljačić, Zagreb/HR C. Comstock, New York/US C. Cyran, Munich/DE M. D Anastasi, Msida/MT M. Fuchsjäger, Graz/AT M. Ginsberg, New York/US M. Gollub, New York/US Th. Helbich, Vienna/AT Ch. Herold, Vienna/AT M. Jochelson, New York/US W. Kunz, Munich/DE A. Laghi, Rome/IT M. Mayerhöfer, Vienna/AT E. Morris, New York/US E. Neri, Pisa/IT K. Pinker-Domenig, Vienna/AT H. Prosch, Vienna/AT M. F. Reiser, Munich/DE J. Ricke, Munich/DE D. Tamandl, Vienna/AT Thank you

3 PARTNERS OIC.8 IS JOINTLY ORGANISED BY OIC.8 IS KINDLY SPONSORED BY

4 & PRESENTED ABSTRACTS WED JUNE 27, 2018 YOUNG RADIOLOGISTS SPECIAL SESSION Imaging Biomarkers Chairs: R. Beets-Tan, Amsterdam/NL 14:30 Welcome and introduction R. Beets-Tan, Amsterdam/NL Imaging Biomarkers for Cancer Diagnosis Invited Lecture 14:40 Imaging biomarkers for cancer diagnosis Presented Abstracts 15:00 Multi-parametric Magnetic Resonance Imaging of Prostate Cancer: Correlation Between ktrans, Gleason Score, and PI-RADS score T. Biondi, Belvedere Marittimo/IT 15:08 Role of diffusion tensor imaging in subtyping of breast cancer with breast MRI P. Clauser, Vienna/AT 15:16 A predictive multiparametric [18F]FDG-PET/MRI model including imaging biomarkers of the tumor and contralateral healthy breast tissue aids breast cancer diagnosis D. Leithner, New York/US 15:24 A novel open-access neural network for evaluation of suspicious masses detected in breast MRI for direct integration into clinical workflows S. Ellmann, Erlangen/DE 15:30 Discussion 15:45 30-minute coffee break Imaging Biomarkers of Tumour Response Invited Lecture 16:15 Imaging biomarkers of tumour response A. Laghi, Rome/IT Presented Abstracts 16:35 A Computer-aided diagnosis (CAD) scheme for pretreatment prediction of pathological complete response (pcr) to neoadjuvant chemotherapy (NAC) in breast cancer patients using dynamic contrastenhanced MRI texture features. V. M. Doronzio, Turin/IT

5 & PRESENTED ABSTRACTS WED JUNE 27, :43 Comparison of RECIST, irecist, and PERCIST for the evaluation of response to PD1-blockage therapy in patients with non-small cell lung cancer L. Beer, Vienna/AT 16:51 CT Texture Analysis in assessing the response to neoadjuvant chemotherapy in Gastric Cancer: preliminary results of a multicenter GIRCG study G. Bagnacci, Siena/IT 16:59 Radiomics as a predictive biomarker of metastatic response to immunotherapy Z. Elkarghali, Amsterdam/NL 17:05 Discussion Keynote Lecture 17:20 How to peer-review a scientific manuscript M. F. Reiser, Munich/DE ESOI Survey Presentation 17:40 Involvement of radiologists in oncologic multidisciplinary teams E. Neri, Pisa/IT 17:55 Discussion

6 THU JUNE 28, 2018 SESSION 1 Essentials for Interpreting Oncologic Imaging Examinations Chairs: 08:15 Welcome and introduction R. Beets-Tan, Amsterdam/NL Ch. Herold, Vienna/AT M. F. Reiser, Munich/DE J. Ricke, Munich/DE 08:20 Language in reporting: Optimising your reports, and what to avoid 08:40 Structured reporting in oncology: Pearls and pitfalls 09:00 Common errors in oncologic imaging 09:20 Panel discussion All speakers session 1 09:40 20-minute coffee break SESSION 2 Thoracic Oncology Chairs: Ch. Herold, Vienna/AT H. Prosch, Vienna/AT 10:00 Pulmonary adenocarcinoma: New classification and implications for management Ch. Herold, Vienna/AT 10:20 Staging of lung cancer: Update on changes H. Prosch, Vienna/AT 10:40 Complications in the treatment of thoracic tumours M. Ginsberg, New York/US 11:00 Chameleons in thoracic oncology H. Prosch, Vienna/AT 11:20 Post radiation therapy in lung imaging M. Ginsberg, New York/US 11:40 Interactive case discussions All speakers session 2 INDUSTRY SESSION PET-MRI body applications 12:00 M. Goyen, Chief Medical Officer Europe (GE Healthcare) 12:15 75-minute lunch break

7 THU JUNE 28, 2018 SESSION 3 GYN Oncology Chairs: 13:30 Imaging as GPS to surgical planning: A surgeon s point of view R. Barakat, New York/US 13:50 Imaging cancer of the endometrium and cervix addressing the key treatment questions 14:10 Imaging spectrum of peritoneal carcinomatosis and mesenteric neoplasms: How the radiologist can help the treatment plan 14:30 Interactive case discussions All speakers session 3 14:50 30-minute coffee break SPECIAL LECTURE 15:20 Future of radiological response criteria in times of liquid biopsy J. Ricke, Munich/DE SESSION 4 GU Oncology Chairs: C. Cyran, Munich/DE 15:40 Key elements in staging renal tumours before laparoscopic surgery M. D Anastasi, Msida/MT 16:00 Prostate MRI in 2018, who should have one and what should we look for 16:20 Functional imaging of prostate cancer: Therapeutic implications C. Cyran, Munich/DE 16:40 Interactive case discussions All speakers session 4 WORKSHOP 1 HANDS-ON Criteria-Based Reporting (RECIST) 17:00 M. D Anastasi, Msida/MT W. Kunz, Munich/DE

8 FRI JUNE 29, 2018 SESSION 5 Gastrointestinal Oncology Chairs: M. Gollub, New York/US A. Laghi, Rome/IT 08:30 Rectal MRI for local staging prior to treatment: Pearls and pitfalls M. Gollub, New York/US 08:50 GIST diagnosis and treatment response assessment with imaging A. Laghi, Rome/IT 09:10 Neuroendocrine tumours M. Mayerhöfer, Vienna/AT 09:30 Imaging biomarkers in gastrointestinal oncology E. Neri, Pisa/IT 09:50 Interactive case discussions All speakers session 5 SESSION 6 Hepatobiliary and Pancreatic Oncology Chairs: J. Ricke, Munich/DE 10:40 How imaging helps us in planning biliary and hepatic surgery D. Tamandl, Vienna/AT 11:00 Liver metastases: Detection and treatment response evaluation 11:20 Biliary tumours: Malignant lesions D. Tamandl, Vienna/AT 11:40 Interactive case discussions All speakers session 6 12:00 90-minute lunch break 10:10 30-minute coffee break

9 FRI JUNE 29, 2018 SPECIAL SESSION Immune Therapy Chairs: M. D Anastasi, Msida/MT M. Mayerhöfer, Vienna/AT 13:30 Development and current indications of immune therapy M. von Bergwelt, Munich/DE 14:00 Assessing response to immune therapy on imaging M. Mayerhöfer, Vienna/AT 14:20 Complications of immune therapy: What the radiologist should be aware of 14:40 Interactive case discussions All speakers special session 14:50 20-minute coffee break SESSION 7 MSK Oncology Chairs: M. F. Reiser, Munich/DE 15:20 Calcified soft tissue tumours: Differential diagnosis A. Baur-Melnyk, Munich/DE 15:40 Post-treatment MRI of soft tissue tumours: What do the oncologist and surgeon want to know? 16:00 Vertebral fractures: Neoplastic or benign? A. Baur-Melnyk, Munich/DE 16:20 Interactive case discussions All speakers session 7 WORKSHOP 2 Response Patterns and Pitfalls associated with Immunotherapy 16:45 C. Cyran, Munich/DE W. Kunz, Munich/DE WORKSHOP 3 HANDS-ON Virtual Colonoscopy An Introduction for Beginners 16:45 A. Laghi, Rome/IT E. Neri, Pisa/IT

10 SAT JUNE 30, 2018 BREAST SESSION 1 Breast Imaging Chairs: Th. Helbich, Vienna/AT E. Morris, New York/US 08:30 Breast imaging with mammogram, US & MRI: When & how? Th. Helbich, Vienna/AT 08:50 Multiparametric US more style than substance? P. Baltzer, Vienna/AT 09:10 Preoperative evaluation using mammography, US & MRI K. Pinker-Domenig, Vienna/AT 09:30 Screening with new modalities: DBT and CEDM M. Jochelson, New York/US 09:50 What will be the future of screening for breast cancer? E. Morris, New York/US BREAST SESSION 2 Breast Imaging Chairs: Th. Helbich, Vienna/AT E. Morris, New York/US 10:40 Computer assisted approaches the future? P. Baltzer, Vienna/AT 11:00 Evaluating treatment response: MRI and PET M. Jochelson, New York/US 11:20 High risk lesions: What is new? B. Brkljačić, Zagreb/HR 11:40 Percutaneous ablation: A way to do less? M. Fuchsjäger, Graz/AT 12:00 90-minute lunch break 10:10 30-minute coffee break

11 SAT JUNE 30, 2018 WORKSHOP 4 Breast Imaging: Challenging Cases 13:30 B. Brkljačić, Zagreb/HR K. Pinker-Domenig, Vienna/AT WORKSHOP 5 Pelvic MRI: Meet the Experts 13:30 M. Gollub, New York/US WORKSHOP 6 Breast Imaging: Challenging Cases 14:30 B. Brkljačić, Zagreb/HR C. Comstock, New York/US WORKSHOP 7 Thoracic Imaging: Challenging Cases 14:30 M. Ginsberg, New York/US